Andrea Ellis, a director at $BBIO, sold 10,000 shares of the company on 04-14-2025 for an estimated $350,000. We received data on the trade from a recent SEC filing. This was a sale of approximately 45.5% of their shares of this class of stock. Following this trade, they now own 12,000 shares of this class of $BBIO stock.
$BBIO Insider Trading Activity
$BBIO insiders have traded $BBIO stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.
Here’s a breakdown of recent trading of $BBIO stock by insiders over the last 6 months:
- GENETIC DISORDER L.P. KKR sold 6,000,000 shares for an estimated $197,760,000
- GLOBAL INVESTORS LP VIKING sold 3,065,616 shares for an estimated $106,989,998
- NEIL KUMAR (Chief Executive Officer) has made 0 purchases and 10 sales selling 808,932 shares for an estimated $28,825,414.
- BRIAN C STEPHENSON (CFO and Treasurer) has made 0 purchases and 5 sales selling 84,804 shares for an estimated $2,992,985.
- ANDREA ELLIS has made 0 purchases and 2 sales selling 40,000 shares for an estimated $1,371,500.
- HANNAH VALANTINE sold 12,875 shares for an estimated $419,499
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BBIO Hedge Fund Activity
We have seen 141 institutional investors add shares of $BBIO stock to their portfolio, and 110 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FARALLON CAPITAL MANAGEMENT LLC added 2,448,000 shares (+140.1%) to their portfolio in Q4 2024, for an estimated $67,173,120
- CITADEL ADVISORS LLC removed 1,686,753 shares (-57.3%) from their portfolio in Q4 2024, for an estimated $46,284,502
- WOODLINE PARTNERS LP added 1,261,772 shares (+132.9%) to their portfolio in Q4 2024, for an estimated $34,623,023
- ASSENAGON ASSET MANAGEMENT S.A. added 1,096,799 shares (+4544.6%) to their portfolio in Q1 2025, for an estimated $37,916,341
- PICTET ASSET MANAGEMENT HOLDING SA removed 995,585 shares (-35.5%) from their portfolio in Q4 2024, for an estimated $27,318,852
- ALYESKA INVESTMENT GROUP, L.P. added 940,415 shares (+inf%) to their portfolio in Q4 2024, for an estimated $25,804,987
- JPMORGAN CHASE & CO removed 916,902 shares (-75.4%) from their portfolio in Q4 2024, for an estimated $25,159,790
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BBIO Analyst Ratings
Wall Street analysts have issued reports on $BBIO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 10/24/2024
To track analyst ratings and price targets for $BBIO, check out Quiver Quantitative's $BBIO forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
